Exploration of the role of METTL3 in tumor glycolysis facilitates the elucidation of the specifics of energy metabolism within tumor cells, which undoubtedly broadens our view of metabolic reprogramming in tumors. The gene discussed is METTL3; the disease is neoplasm.